On December 16, 2022, Carol L. Brosgart, M.D., notified the board of directors of Mirum Pharmaceuticals, Inc. of her resignation as a director of the Company and as a member of the Nominating and Corporate Governance Committee of the Board, effective December 19, 2022. Following Dr. Brosgart's resignation, she plans to assume a new role as the Company's senior advisor in science and policy.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.92 USD | -2.85% | +3.39% | -12.20% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.20% | 1.22B | |
+40.80% | 53.67B | |
+35.79% | 38.86B | |
-8.05% | 38.76B | |
-8.98% | 27.27B | |
+10.69% | 25.91B | |
-16.21% | 20.29B | |
+31.00% | 12.78B | |
+28.51% | 12.18B | |
-1.67% | 11.96B |
- Stock Market
- Equities
- MIRM Stock
- News Mirum Pharmaceuticals, Inc.
- Mirum Pharmaceuticals, Inc. Announces Resignation of Carol L. Brosgart, M.D. as A Director of the Company and as A Member of the Nominating and Corporate Governance Committee of the Board, Effective December 19, 2022